BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18702436)

  • 1. Successful treatment of aggressive HIV-associated multicentric Castleman's disease: a case report.
    Flejsierowicz M; Ahmed MS; Kotov P; Cheng YC
    WMJ; 2008 Jul; 107(4):191-4. PubMed ID: 18702436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody.
    Gholam D; Vantelon JM; Al-Jijakli A; Bourhis JH
    Ann Hematol; 2003 Dec; 82(12):766-8. PubMed ID: 12898190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of human immunodeficiency virus-related Castleman's disease: a case report and literature review.
    Liberopoulos E; Tolis C; Bai M; Efremidis S; Pavlidis N; Elisaf M
    Oncology; 2003; 65(2):182-6. PubMed ID: 12931026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicentric Castleman's disease & HIV infection.
    Cotter A; Lambert J; O'Gorman P
    Ir Med J; 2009 Oct; 102(9):294-5. PubMed ID: 19902650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autoimmune hemolytic anemia associated with multicentric Castleman's disease with a 28-year history].
    Hisatake J; Ishiyama T; Akimoto Y; Matsuda I; Hino K; Tomoyasu S; Tsuruoka N; Ota H; Kazama K
    Rinsho Ketsueki; 1994 Aug; 35(8):768-73. PubMed ID: 7933564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena.
    Ocio EM; Sanchez-Guijo FM; Diez-Campelo M; Castilla C; Blanco OJ; Caballero D; San Miguel JF
    Am J Hematol; 2005 Apr; 78(4):302-5. PubMed ID: 15795923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of multicentric Castleman's disease in HIV infection with the rare complication of acquired angioedema.
    Fernando I; Scott G
    Int J STD AIDS; 2014 Jun; 25(7):523-5. PubMed ID: 24352125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial.
    Gérard L; Bérezné A; Galicier L; Meignin V; Obadia M; De Castro N; Jacomet C; Verdon R; Madelaine-Chambrin I; Boulanger E; Chevret S; Agbalika F; Oksenhendler E
    J Clin Oncol; 2007 Aug; 25(22):3350-6. PubMed ID: 17664482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vinblastine, rituximab and HAART, treatment of an HIV -positive patient with multicentric Castleman's disease.
    van Aalderen MC; Brinkman K; van den Berk GE; Terpstra WE
    Neth J Med; 2010 Feb; 68(2):87-90. PubMed ID: 20167961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term remission in HIV-negative patients with multicentric Castleman's disease using rituximab.
    Ide M; Kawachi Y; Izumi Y; Kasagi K; Ogino T
    Eur J Haematol; 2006 Feb; 76(2):119-23. PubMed ID: 16405432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicentric Castleman's disease treated with combination chemotherapy and rituximab in four HIV-positive men: a case series.
    Bestawros A; Michel R; Séguin C; Routy JP
    Am J Hematol; 2008 Jun; 83(6):508-11. PubMed ID: 18027834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients.
    Oksenhendler E; Duarte M; Soulier J; Cacoub P; Welker Y; Cadranel J; Cazals-Hatem D; Autran B; Clauvel JP; Raphael M
    AIDS; 1996 Jan; 10(1):61-7. PubMed ID: 8924253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of HIV-associated lymphoma-recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG).
    Hentrich M; Hoffmann C; Mosthaf F; Müller M; Siehl J; Wyen C; Hensel M; ;
    Ann Hematol; 2014 Jun; 93(6):913-21. PubMed ID: 24807241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentric Castleman's disease in HIV infection: a systematic review of the literature.
    Mylona EE; Baraboutis IG; Lekakis LJ; Georgiou O; Papastamopoulos V; Skoutelis A
    AIDS Rev; 2008; 10(1):25-35. PubMed ID: 18385778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Two HHV8-related illnesses in a HIV-negative patient: Kaposi's sarcoma and multicentric Castleman's disease. Response to treatment with Rituximab and CHOP].
    Pastor MA; Vasco B; Mosquera JM; Debén G; Bautista P; Requena L
    Actas Dermosifiliogr; 2006; 97(6):385-90. PubMed ID: 16956518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicentric Castleman's disease in a patient with HIV.
    Fowler A; Collins L; de Ruiter A; Whittaker S; Kulasegaram R; Bradbeer C
    Int J STD AIDS; 2006 Jan; 17(1):63-4. PubMed ID: 16409683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.
    Zimmermann H; Reinke P; Neuhaus R; Lehmkuhl H; Oertel S; Atta J; Planker M; Gärtner B; Lenze D; Anagnostopoulos I; Riess H; Trappe RU
    Cancer; 2012 Oct; 118(19):4715-24. PubMed ID: 22392525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial.
    Ribera JM; Oriol A; Morgades M; González-Barca E; Miralles P; López-Guillermo A; Gardella S; López A; Abella E; García M;
    Br J Haematol; 2008 Feb; 140(4):411-9. PubMed ID: 18162120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Life-threatening interaction between antiretroviral therapy and vinblastine in HIV-associated multicentric Castleman's disease.
    Kotb R; Vincent I; Dulioust A; Peretti D; Taburet AM; Delfraissy JF; Goujard C
    Eur J Haematol; 2006 Mar; 76(3):269-71. PubMed ID: 16451402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete remission in 4 patients with human herpesvirus 8-associated multicentric Castleman disease using rituximab and liposomal doxorubicin, a novel chemotherapy combination.
    Peker D; Martinez AE; Schwartz MA; Cusnir M
    Clin Adv Hematol Oncol; 2012 Mar; 10(3):204-6. PubMed ID: 22402431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.